Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cajal Neuroscience
company
About
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
- Seattle,Washington,United States
- 101 - 250
- https://cajalneuro.com
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $96M
- Industries
- Biotechnology,Neuroscience,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2020
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Cajal Neuroscience is a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration. The company combines a suite of state-of-the-art approaches and technologies, including integrative human genetics and multi-omics, high-throughput functional genomics, and advanced microscopy, to accelerate neurodegeneration target and drug discovery.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$96M
Cajal Neuroscience has raised a total of
$96M
in funding over 2 rounds. Their latest funding was raised on
Nov 29, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 29, 2022 | Series A | $96M | 7 |
Lux Capital
The Column Group
|
— | Detail |
| Jan 1, 2020 | Seed | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
7
Cajal Neuroscience is funded by 7 investors.
Lux Capital
and The Column Group
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lux Capital
|
Yes | Series A |
|
The Column Group
|
Yes | Series A |
Alexandria Venture Investments
|
— | Series A |
Bristol Myers Squibb
|
— | Series A |
Dolby Family Ventures
|
— | Series A |
Evotec
|
— | Series A |
Two Sigma Ventures
|
— | Series A |
Employee Profiles
Number of Employee Profiles
10
Cajal Neuroscience has 10 current employee profiles, including
Board member Josh Wolfe
Board member
Executive
Board member
Executive
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
